CTKB – Cytek Biosciences, Inc.
Cytek Biosciences, Inc.CTKB
$2.98Name : Cytek Biosciences, Inc.
Sector : Healthcare
Industry: Medical Devices
Mark. Cap: $377,443,808.00
EPSttm : -0.09
Cytek Biosciences, Inc.
$2.98
1.32%$0.04Float Short %
3.65
Margin Of Safety %
6
Put/Call OI Ratio
0.22
EPS Next Q Diff
0.12
EPS Last/This Y
0.16
EPS This/Next Y
0.08
Price
2.98
Target Price
6
Analyst Recom
2.67
Performance Q
-42.69
Relative Volume
1.54
Beta
1.33
Ticker: CTKB
of 1
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2025-04-14 | CTKB | 3.76 | 5.42 | 999.99 | 77 |
| 2025-04-15 | CTKB | 3.71 | 5.50 | 999.99 | 78 |
| 2025-04-16 | CTKB | 3.66 | 14.67 | 999.99 | 188 |
| 2025-04-17 | CTKB | 3.65 | 14.67 | 999.99 | 188 |
| 2025-04-18 | CTKB | 3.65 | 14.67 | 999.99 | 188 |
| 2025-04-21 | CTKB | 3.71 | 14.67 | 999.99 | 188 |
| 2025-04-22 | CTKB | 3.78 | 14.67 | 999.99 | 188 |
| 2025-04-23 | CTKB | 3.77 | 14.67 | 999.99 | 188 |
| 2025-04-24 | CTKB | 3.81 | 1.25 | 0.00 | 9 |
| 2025-04-25 | CTKB | 3.77 | 0.20833333333333 | 1 | 29 |
| 2025-04-28 | CTKB | 3.86 | 0.20833333333333 | 1 | 29 |
| 2025-04-29 | CTKB | 3.74 | 0.21 | 1.00 | 29 |
| 2025-04-30 | CTKB | 3.7 | 0.24 | 0.00 | 31 |
| 2025-05-01 | CTKB | 3.69 | 0.24 | 0.00 | 31 |
| 2025-05-02 | CTKB | 3.86 | 0.24 | 0.00 | 31 |
| 2025-05-05 | CTKB | 3.79 | 0.24 | 0.00 | 31 |
| 2025-05-06 | CTKB | 3.67 | 0.24 | 0.00 | 31 |
| 2025-05-07 | CTKB | 3.71 | 0.24 | 0.00 | 31 |
| 2025-05-08 | CTKB | 3.78 | N/A | N/A | 0 |
| 2025-05-09 | CTKB | 2.92 | 0.22 | 0.00 | 33 |
| 2025-05-12 | CTKB | 3 | 0.22 | 0.00 | 33 |
| 2025-05-13 | CTKB | 2.97 | 0.22 | 0.00 | 33 |
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2025-04-14 | CTKB | 3.76 | 186.2 | - | 0.11 |
| 2025-04-15 | CTKB | 3.72 | 186.2 | - | 0.11 |
| 2025-04-16 | CTKB | 3.68 | 186.2 | - | 0.11 |
| 2025-04-17 | CTKB | 3.65 | 186.2 | - | 0.11 |
| 2025-04-18 | CTKB | 3.65 | 186.2 | - | 0.11 |
| 2025-04-21 | CTKB | 3.71 | 186.2 | - | 0.11 |
| 2025-04-22 | CTKB | 3.79 | 186.2 | - | 0.11 |
| 2025-04-23 | CTKB | 3.77 | 186.2 | - | 0.11 |
| 2025-04-24 | CTKB | 3.81 | 186.2 | - | 0.11 |
| 2025-04-25 | CTKB | 3.77 | 186.2 | - | 0.11 |
| 2025-04-28 | CTKB | 3.86 | 186.2 | - | 0.11 |
| 2025-04-29 | CTKB | 3.75 | 186.2 | - | 0.11 |
| 2025-04-30 | CTKB | 3.70 | 186.2 | - | 0.11 |
| 2025-05-01 | CTKB | 3.69 | 186.2 | - | 0.11 |
| 2025-05-02 | CTKB | 3.86 | 186.2 | - | 0.11 |
| 2025-05-05 | CTKB | 3.80 | 186.2 | - | 0.11 |
| 2025-05-06 | CTKB | 3.67 | 186.2 | - | 0.11 |
| 2025-05-07 | CTKB | 3.73 | 186.2 | - | 0.11 |
| 2025-05-08 | CTKB | 3.79 | 186.2 | - | 0.11 |
| 2025-05-09 | CTKB | 2.92 | 186.2 | - | 0.11 |
| 2025-05-12 | CTKB | 3.02 | 186.2 | - | 0.11 |
| 2025-05-13 | CTKB | 2.98 | 231.6 | - | 0.11 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2025-04-14 | CTKB | 0.00 | 3.35 | 3.91 |
| 2025-04-15 | CTKB | 0.00 | 3.35 | 3.91 |
| 2025-04-16 | CTKB | 0.00 | 3.35 | 3.91 |
| 2025-04-17 | CTKB | 0.00 | 3.35 | 3.91 |
| 2025-04-18 | CTKB | 0.00 | 3.35 | 3.91 |
| 2025-04-21 | CTKB | 0.00 | 3.11 | 3.91 |
| 2025-04-22 | CTKB | 0.00 | 3.11 | 3.91 |
| 2025-04-23 | CTKB | 0.00 | 3.11 | 3.91 |
| 2025-04-24 | CTKB | 0.00 | 3.11 | 3.91 |
| 2025-04-25 | CTKB | 0.00 | 3.11 | 3.91 |
| 2025-04-28 | CTKB | 0.00 | 3.16 | 3.56 |
| 2025-04-29 | CTKB | 0.00 | 3.16 | 3.56 |
| 2025-04-30 | CTKB | 0.00 | 3.16 | 3.56 |
| 2025-05-01 | CTKB | 0.00 | 3.16 | 3.56 |
| 2025-05-02 | CTKB | 0.00 | 3.16 | 3.58 |
| 2025-05-05 | CTKB | 0.00 | 2.84 | 3.58 |
| 2025-05-06 | CTKB | 0.00 | 2.84 | 3.58 |
| 2025-05-07 | CTKB | 0.00 | 2.84 | 3.58 |
| 2025-05-08 | CTKB | 0.00 | 2.84 | 3.58 |
| 2025-05-09 | CTKB | 0.00 | 2.84 | 3.58 |
| 2025-05-12 | CTKB | 0.00 | -1.58 | 3.65 |
| 2025-05-13 | CTKB | 0.00 | -1.58 | 3.65 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
-0.09
Avg. EPS Est. Current Quarter
0.01
Avg. EPS Est. Next Quarter
0.03
Insider Transactions
Institutional Transactions
-1.58
Beta
1.33
Average Sales Estimate Current Quarter
47
Average Sales Estimate Next Quarter
53
Fair Value
3.17
Quality Score
47
Growth Score
47
Sentiment Score
3
Actual DrawDown %
89.6
Max Drawdown 5-Year %
Target Price
6
P/E
Forward P/E
PEG
P/S
1.92
P/B
1
P/Free Cash Flow
21.58
EPS
-0.09
Average EPS Est. Cur. Y
0.11
EPS Next Y. (Est.)
0.19
Target Price Estimates Raised
Target Price Estimates Lowered
1
Profit Margin
-5.71
Relative Volume
1.54
Return on Equity vs Sector %
-26.7
Return on Equity vs Industry %
-21
EPS 1 7Days Diff
EPS 1 30Days Diff
-0.04
EBIT Estimation
Cytek Biosciences, Inc.Sector: Healthcare
Industry: Medical Devices
Employees: 663
Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. The company offers aurora and northern lights systems delivers cell analysis; aurora cell sorter system that leverages full spectrum profiling technology to further broaden potential applications across cell analysis; enhanced small particle detection; amnis imagestream imaging flow cytometers; guava muse cell analyzers; guava easycyte flow cytometers; and orion reagent cocktail preparation systems. It also provides reagents and kits, including cFluor reagents that are fluorochrome conjugated antibodies used to identify cells of interest for analysis on its instruments. In addition, the company offers automated micro-sampling system and automated sample loader system, an automated loaders designed to integrate seamlessly into the aurora and northern lights systems; SpectroFlo software that provides intuitive workflow from quality control to data analysis for aurora and northern lights systems; and customer support tools. It serves pharmaceutical and biopharma companies, academic research centers, and clinical research organizations. The company distributes its products through direct sales force and support organizations in North America, Europe, China, and the Asia-Pacific regions; and through distributors or sales agents in Europe, Latin America, and the Middle East countries. The company was formerly known as Cytoville, Inc. and changed its name to Cytek Biosciences, Inc. in August 2015. Cytek Biosciences, Inc. was founded in 1992 and is headquartered in Fremont, California.
stock quote shares CTKB – Cytek Biosciences, Inc. Stock Price stock today
news today CTKB – Cytek Biosciences, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch CTKB – Cytek Biosciences, Inc. yahoo finance google finance
stock history CTKB – Cytek Biosciences, Inc. invest stock market
stock prices CTKB premarket after hours
ticker CTKB fair value insiders trading